Suppr超能文献

CD22 和 Siglec-G 在 B 细胞功能和耐受中的作用。

CD22 and Siglec-G in B cell function and tolerance.

机构信息

Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Trends Immunol. 2012 Aug;33(8):413-20. doi: 10.1016/j.it.2012.04.010. Epub 2012 Jun 5.

Abstract

The immune system has evolved into two main arms: the primitive innate arm that is the first line of defense but relatively short-lived and broad acting; and the advanced adaptive arm that generates immunological memory, allowing rapid, specific recall responses. T cell-independent type-2 (TI-2) antigens (Ags) invoke innate immune responses. However, due to its 'at the ready' nature, how the innate arm of the immune system maintains tolerance to potentially abundant host TI-2 Ags remains elusive. Therefore, it is important to define the mechanisms that establish innate immune tolerance. This review highlights recent insights into B cell tolerance to theoretical self TI-2 Ags, and examines how the B cell-restricted sialic acid binding Ig-like lectins (Siglecs), CD22 and Siglec-G, might contribute to this process.

摘要

免疫系统已经进化成两个主要分支

原始的先天分支,是第一道防线,但相对寿命短且作用广泛;以及先进的适应性分支,它产生免疫记忆,允许快速、特异性的回忆反应。T 细胞非依赖性 2 型(TI-2)抗原(Ag)引发先天免疫反应。然而,由于其“随时待命”的性质,免疫系统的先天分支如何对潜在丰富的宿主 TI-2 Ag 保持耐受仍然难以捉摸。因此,确定建立先天免疫耐受的机制非常重要。这篇综述强调了最近对理论上自身 TI-2 Ag 中 B 细胞耐受的新认识,并探讨了 B 细胞限制性唾液酸结合免疫球蛋白样凝集素(Siglec)CD22 和 Siglec-G 如何有助于这一过程。

相似文献

1
CD22 and Siglec-G in B cell function and tolerance.
Trends Immunol. 2012 Aug;33(8):413-20. doi: 10.1016/j.it.2012.04.010. Epub 2012 Jun 5.
2
Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
J Immunol. 2018 Feb 1;200(3):949-956. doi: 10.4049/jimmunol.1701257. Epub 2017 Dec 29.
4
CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Glycobiology. 2014 Sep;24(9):807-17. doi: 10.1093/glycob/cwu066. Epub 2014 Jul 6.
5
Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
J Immunol. 2013 Aug 15;191(4):1724-31. doi: 10.4049/jimmunol.1300921. Epub 2013 Jul 8.
6
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
Nat Rev Rheumatol. 2014 Jul;10(7):422-8. doi: 10.1038/nrrheum.2014.54. Epub 2014 Apr 29.
8
B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Front Immunol. 2018 Dec 3;9:2820. doi: 10.3389/fimmu.2018.02820. eCollection 2018.
9
Sialic acids and autoimmune disease.
Immunol Rev. 2016 Jan;269(1):145-61. doi: 10.1111/imr.12344.
10
CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
J Immunol. 2018 Mar 1;200(5):1671-1681. doi: 10.4049/jimmunol.1701578. Epub 2018 Jan 26.

引用本文的文献

1
Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines.
Nanomedicine (Lond). 2025 Sep;20(18):2375-2391. doi: 10.1080/17435889.2025.2538423. Epub 2025 Jul 29.
2
Biomaterial engineering strategies for B cell immunity modulations.
Biomater Sci. 2024 Apr 16;12(8):1981-2006. doi: 10.1039/d3bm01841e.
3
Xist ribonucleoproteins promote female sex-biased autoimmunity.
Cell. 2024 Feb 1;187(3):733-749.e16. doi: 10.1016/j.cell.2023.12.037.
4
Activation of immune signals during organ transplantation.
Signal Transduct Target Ther. 2023 Mar 11;8(1):110. doi: 10.1038/s41392-023-01377-9.
5
Core Fucosylation Regulates the Function of Pre-BCR, BCR and IgG in Humoral Immunity.
Front Immunol. 2022 Mar 25;13:844427. doi: 10.3389/fimmu.2022.844427. eCollection 2022.
7
Therapeutic Potential of B-1a Cells in COVID-19.
Shock. 2020 Nov;54(5):586-594. doi: 10.1097/SHK.0000000000001610.
9
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Biomark Res. 2019 Apr 11;7:9. doi: 10.1186/s40364-019-0160-4. eCollection 2019.
10
RNA-binding protein Ptbp1 is essential for BCR-mediated antibody production.
Int Immunol. 2019 Mar 5;31(3):157-166. doi: 10.1093/intimm/dxy077.

本文引用的文献

1
Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo.
J Immunol. 2012 Feb 1;188(3):1036-48. doi: 10.4049/jimmunol.1102500. Epub 2011 Dec 23.
2
CD22 serves as a receptor for soluble IgM.
Eur J Immunol. 2012 Jan;42(1):241-7. doi: 10.1002/eji.201141899. Epub 2011 Nov 10.
3
Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice.
PLoS One. 2011;6(7):e22464. doi: 10.1371/journal.pone.0022464. Epub 2011 Jul 25.
4
CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.
J Immunol. 2011 Feb 1;186(3):1554-63. doi: 10.4049/jimmunol.1003005. Epub 2010 Dec 22.
5
Siglec-G regulates B1 cell survival and selection.
J Immunol. 2010 Sep 15;185(6):3277-84. doi: 10.4049/jimmunol.1001792. Epub 2010 Aug 20.
6
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes.
Blood. 2010 Sep 9;116(10):1698-704. doi: 10.1182/blood-2009-12-261461. Epub 2010 Jun 1.
7
B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.
Int Immunol. 2010 Aug;22(8):681-91. doi: 10.1093/intimm/dxq055. Epub 2010 May 31.
8
CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
J Immunol. 2010 Apr 1;184(7):3618-27. doi: 10.4049/jimmunol.0902711. Epub 2010 Mar 3.
9
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer.
Ann N Y Acad Sci. 2010 Jan;1183:38-57. doi: 10.1111/j.1749-6632.2009.05137.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验